Drreddys Laboratories | RDY - Stammkapital





Stammkapital Veränderung Datum
ANI Pharmaceuticals USD 22.49M 760K 2025-12
Aurora Cannabis CAD 6.98B 907K 2024-12
Bayer EUR 982.42M 0 2025-12
Canopy Growth CAD 332.38M 127.23M 2025-09
Cipla INR 807.77M 807.43M 2025-09
Corcept Therapeutics USD 105.97M 842K 2025-12
Drreddys Laboratories INR 832.57M 53K 2025-12
GlaxoSmithKline GBP 4.08B 49.43M 2025-12
Hikma Pharmaceutical USD 221.89M 181.89M 2025-12
Lonza CHF 72M 0 2024-12
Novartis USD 1.94B 23.4M 2025-06
Pacira USD 41.12M 1.85M 2025-12
Phibro Animal Health USD 40.48M 0 2025-12
Prestige Brands USD 48.08M 47.52M 2025-09
Richter Gedeon HUF 179.35M 0 2025-12
Sun Pharmaceuticals INR 2.4B 35K 2025-09
Supernus Pharmaceuticals USD 57.12M 1000K 2025-09
Teva Pharmaceutical Industries USD 1.15B 0 2025-12